KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rigel Pharmaceuticals (RIGL) Return on Equity (2016 - 2025)

Historic Return on Equity for Rigel Pharmaceuticals (RIGL) over the last 15 years, with Q3 2025 value amounting to 1.14%.

  • Rigel Pharmaceuticals' Return on Equity rose 13100.0% to 1.14% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.14%, marking a year-over-year increase of 13100.0%. This contributed to the annual value of 1.38% for FY2024, which is 25700.0% down from last year.
  • Latest data reveals that Rigel Pharmaceuticals reported Return on Equity of 1.14% as of Q3 2025, which was up 13100.0% from 1.95% recorded in Q2 2025.
  • In the past 5 years, Rigel Pharmaceuticals' Return on Equity ranged from a high of 7.02% in Q3 2022 and a low of 54.15% during Q2 2022
  • Moreover, its 5-year median value for Return on Equity was 0.66% (2024), whereas its average is 2.07%.
  • In the last 5 years, Rigel Pharmaceuticals' Return on Equity crashed by -540400bps in 2022 and then surged by 555900bps in 2023.
  • Rigel Pharmaceuticals' Return on Equity (Quarter) stood at 0.45% in 2021, then surged by 884bps to 3.5% in 2022, then plummeted by -76bps to 0.83% in 2023, then crashed by -471bps to 3.08% in 2024, then surged by 137bps to 1.14% in 2025.
  • Its last three reported values are 1.14% in Q3 2025, 1.95% for Q2 2025, and 3.4% during Q1 2025.